Dr. Kevan Herold

Biography

Dr. Kevan Herold is the C.N.H. Long Professor of Immunobiology and Medicine (Endocrinology) at Yale School of Medicine. His research focuses on the pathogenesis and treatment of autoimmune diseases, particularly Type 1 diabetes. His lab conducts clinical trials and investigations to explore the immune system's role in the disease, including studies on novel therapeutic approaches. Dr. Herold's work includes examining the mechanisms by which T cells destroy insulin-producing beta cells and analyzing the immune responses in diabetic patients, especially in the context of those with cancer being treated with checkpoint inhibitors. Throughout the COVID-19 pandemic, he has also researched the immunological responses in hospitalized children and adults. Dr. Herold holds an MD from Jefferson Medical College and has completed his residency at Temple University Hospital. He trained as a fellow at the University of Chicago and has been involved in significant clinical trials, including those evaluating the efficacy of new treatments for Type 1 diabetes. As a leading expert in his field, he aims to deepen the understanding of diabetes mechanisms and to develop innovative treatments that can improve patient outcomes.

Research Interests